Logo image of CNP.PA

(CNP.PA) Stock Fundamental Analysis

EPA:CNP - Euronext Paris - Matif - FR0000120222 - Currency: EUR

20.82  -0.08 (-0.38%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to CNP. CNP was compared to 39 industry peers in the Insurance industry. CNP may be in some trouble as it scores bad on both profitability and health. CNP is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year CNP was profitable.
CNP.PA Yearly Net Income VS EBIT VS OCF VS FCFCNP.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2B 4B 6B 8B 10B

1.2 Ratios

Industry RankSector Rank
ROA 0.32%
ROE 7.34%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CNP.PA Yearly ROA, ROE, ROICCNP.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2 4 6

1.3 Margins

CNP does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 3.54%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CNP.PA Yearly Profit, Operating, Gross MarginsCNP.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2 4 6

0

2. Health

2.1 Basic Checks

The number of shares outstanding for CNP remains at a similar level compared to 1 year ago.
Compared to 1 year ago, CNP has a worse debt to assets ratio.
CNP.PA Yearly Shares OutstandingCNP.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 200M 400M 600M
CNP.PA Yearly Total Debt VS Total AssetsCNP.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 100B 200B 300B 400B

2.2 Solvency

A Debt/Equity ratio of 1.23 is on the high side and indicates that CNP has dependencies on debt financing.
Industry RankSector Rank
Debt/Equity 1.23
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACCN/A
CNP.PA Yearly LT Debt VS Equity VS FCFCNP.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 5B 10B 15B 20B 25B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A

5

3. Growth

3.1 Past

CNP shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 14.93%, which is quite good.
The Earnings Per Share has been growing slightly by 5.28% on average over the past years.
The Revenue has grown by 26.10% in the past year. This is a very strong growth!
CNP shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.67% yearly.
EPS 1Y (TTM)14.93%
EPS 3Y4.34%
EPS 5Y5.28%
EPS Q2Q%19.5%
Revenue 1Y (TTM)26.1%
Revenue growth 3Y5.44%
Revenue growth 5Y0.67%
Sales Q2Q%-8.25%

3.2 Future

The Earnings Per Share is expected to grow by 4.11% on average over the next years.
The Revenue is expected to grow by 4.43% on average over the next years.
EPS Next Y4.38%
EPS Next 2Y4.44%
EPS Next 3Y4.32%
EPS Next 5Y4.11%
Revenue Next Year5.27%
Revenue Next 2Y12.83%
Revenue Next 3Y4.34%
Revenue Next 5Y4.43%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CNP.PA Yearly Revenue VS EstimatesCNP.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 10B 20B 30B 40B
CNP.PA Yearly EPS VS EstimatesCNP.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2 2.5

3

4. Valuation

4.1 Price/Earnings Ratio

CNP is valuated reasonably with a Price/Earnings ratio of 9.21.
The average S&P500 Price/Earnings ratio is at 27.50. CNP is valued rather cheaply when compared to this.
The Price/Forward Earnings ratio is 9.27, which indicates a very decent valuation of CNP.
CNP's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 36.44.
Industry RankSector Rank
PE 9.21
Fwd PE 9.27
CNP.PA Price Earnings VS Forward Price EarningsCNP.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 14.19
CNP.PA Per share dataCNP.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CNP does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)2.11
PEG (5Y)1.75
EPS Next 2Y4.44%
EPS Next 3Y4.32%

5

5. Dividend

5.1 Amount

CNP has a Yearly Dividend Yield of 4.80%, which is a nice return.
Compared to an average S&P500 Dividend Yield of 2.35, CNP pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.8%

5.2 History

The dividend of CNP has a limited annual growth rate of 3.96%.
Dividend Growth(5Y)3.96%
Div Incr YearsN/A
Div Non Decr YearsN/A
CNP.PA Yearly Dividends per shareCNP.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 0.5 1 1.5

5.3 Sustainability

CNP pays out 84.68% of its income as dividend. This is not a sustainable payout ratio.
The dividend of CNP is growing around the same rate as the earnings are growing. If this keeps up the dividend growth is sustainable.
DP84.68%
EPS Next 2Y4.44%
EPS Next 3Y4.32%
CNP.PA Yearly Income VS Free CF VS DividendCNP.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2B 4B 6B 8B 10B
CNP.PA Dividend Payout.CNP.PA Dividend Payout, showing the Payout Ratio.CNP.PA Dividend Payout.PayoutRetained Earnings

EPA:CNP (6/3/2022, 7:00:00 PM)

20.82

-0.08 (-0.38%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap14.29B
Analysts44.44
Price Target21.83 (4.85%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.8%
Yearly Dividend1
Dividend Growth(5Y)3.96%
DP84.68%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 9.21
Fwd PE 9.27
P/S 0.33
P/FCF N/A
P/OCF N/A
P/B 0.68
P/tB N/A
EV/EBITDA 14.19
EPS(TTM)2.26
EY10.85%
EPS(NY)2.25
Fwd EY10.79%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS63.87
BVpS30.8
TBVpSN/A
PEG (NY)2.11
PEG (5Y)1.75
Profitability
Industry RankSector Rank
ROA 0.32%
ROE 7.34%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 3.54%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 1.23
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)14.93%
EPS 3Y4.34%
EPS 5Y5.28%
EPS Q2Q%19.5%
EPS Next Y4.38%
EPS Next 2Y4.44%
EPS Next 3Y4.32%
EPS Next 5Y4.11%
Revenue 1Y (TTM)26.1%
Revenue growth 3Y5.44%
Revenue growth 5Y0.67%
Sales Q2Q%-8.25%
Revenue Next Year5.27%
Revenue Next 2Y12.83%
Revenue Next 3Y4.34%
Revenue Next 5Y4.43%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A